Witnessing the stock’s movement on the chart, on Wednesday, Vanda Pharmaceuticals Inc (NASDAQ: VNDA) set off with pace as it heaved 4.22% to $5.19, before settling in for the price of $4.98 at the close. Taking a more long-term approach, VNDA posted a 52-week range of $3.46-$6.75.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 1.11%. Meanwhile, its Annual Earning per share during the time was -37.98%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -891.67%. This publicly-traded company’s shares outstanding now amounts to $57.53 million, simultaneously with a float of $55.21 million. The organization now has a market capitalization sitting at $315.38 million. At the time of writing, stock’s 50-day Moving Average stood at $4.81, while the 200-day Moving Average is $4.99.
Vanda Pharmaceuticals Inc (VNDA) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Vanda Pharmaceuticals Inc’s current insider ownership accounts for 5.31%, in contrast to 76.69% institutional ownership. According to the most recent insider trade that took place on Nov 14 ’24, this organization’s Director sold 5,000 shares at the rate of 5.17, making the entire transaction reach 25,863 in total value, affecting insider ownership by 44,857.
Vanda Pharmaceuticals Inc (VNDA) Earnings and Revenue Records
Vanda Pharmaceuticals Inc’s EPS decrease for this current 12-month fiscal period is -891.67% and is forecasted to reach 0.16 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 36.10% through the next 5 years, which can be compared against the -37.98% growth it accomplished over the previous five years trading on the market.
Vanda Pharmaceuticals Inc (NASDAQ: VNDA) Trading Performance Indicators
Let’s observe the current performance indicators for Vanda Pharmaceuticals Inc (VNDA). It’s Quick Ratio in the last reported quarter now stands at 4.84. The Stock has managed to achieve an average true range (ATR) of 0.22. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1.65.
In the same vein, VNDA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.28, a figure that is expected to reach -0.11 in the next quarter, and analysts are predicting that it will be 0.16 at the market close of one year from today.
Technical Analysis of Vanda Pharmaceuticals Inc (VNDA)
Going through the that latest performance of [Vanda Pharmaceuticals Inc, VNDA]. Its last 5-days volume of 0.56 million was inferior to the volume of 1.27 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 39.31% While, its Average True Range was 0.22.
Raw Stochastic average of Vanda Pharmaceuticals Inc (VNDA) in the period of the previous 100 days is set at 41.69%, which indicates a major fall in contrast to 51.03% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 42.90% that was higher than 42.36% volatility it exhibited in the past 100-days period.
